Factors that deregulate the protective immune response in tuberculosis
- 18 August 2009
- journal article
- review article
- Published by Walter de Gruyter GmbH in Archivum Immunologiae et Therapiae Experimentalis
- Vol. 57 (5), 355-367
- https://doi.org/10.1007/s00005-009-0042-9
Abstract
Tuberculosis (TB) is a chronic infectious disease which essentially affects the lungs and produces profound abnormalities on the immune system. Although most people infected by the tubercle bacillus (90%) do not develop the disease during their lifetime, when there are alterations in the immune system, such as co-infection with HIV, malnutrition, or diabetes, the risk of developing active disease increases considerably. Interestingly, during the course of active disease, even in the absence of immunosuppressive conditions, there is a profound and prolonged suppression of Mycobacterium tuberculosis-specific protective immune responses. Several immune factors can contribute to downregulate the protective immunity, permitting disease progression. In general, many of these factors are potent anti-inflammatory molecules that are probably overproduced with the intention to protect against tissue damage, but the consequence of this response is a decline in protective immunity facilitating bacilli growth and disease progression. Here the most significant participants in protective immunity are reviewed, in particular the factors that deregulate protective immunity in TB. Their manipulation as novel forms of immunotherapy are also briefly commented.Keywords
This publication has 148 references indexed in Scilit:
- The Potential Role of Lung Epithelial Cells and β‐defensins in Experimental Latent TuberculosisScandinavian Journal of Immunology, 2008
- Rab14 is critical for maintenance of Mycobacterium tuberculosis phagosome maturation arrestThe EMBO Journal, 2006
- β‐Defensin Gene Expression during the Course of Experimental Tuberculosis InfectionThe Journal of Infectious Diseases, 2006
- A combination of a transforming growth factor-β antagonist and an inhibitor of cyclooxygenase is an effective treatment for murine pulmonary tuberculosisClinical and Experimental Immunology, 2006
- Expression of inducible nitric oxide synthase and nitrotyrosineduring the evolution of experimental pulmonary tuberculosisExperimental and Toxicologic Pathology, 2001
- The mannose receptor functions as a high capacity and broad specificity antigen receptor in human dendritic cellsEuropean Journal of Immunology, 1997
- Urinary adrenal steroid metabolites in tuberculosis--a new clue to pathogenesis?QJM: An International Journal of Medicine, 1996
- Hormones, peripherally activated prohormones and regulation of the Th1/Th2 balanceImmunology Today, 1994
- The acute phase responseImmunology Today, 1994
- Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation.The Journal of Experimental Medicine, 1993